NT-ProBNP serum levels reflect severity and extent of ischemia in patients admitted with non-ST-elevation acute coronary syndrome

Acute Cardiac Care

Volumn 8, Issue 1, 2006, Pages 51-57

  Riezebos, Robert ^a   Ronner, Eelko ^a   Tijssen, Jan ^b   Laarman, Gert Jan ^a  

^a ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Coronary angiography; Natriuretic peptides; Unstable angina

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOCHEMICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CREATINE KINASE MB; TROPONIN T; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HUMAN; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; ST SEGMENT ELEVATION;

ACUTE DISEASE; AGED; ANGINA, UNSTABLE; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; CREATINE KINASE, MB FORM; DISEASE PROGRESSION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; PROTEIN PRECURSORS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TROPONIN I;

EID: 33745713828     PISSN: 17482941     EISSN: 1748295X     Source Type: Journal    
DOI: 10.1080/14628840600627972     Document Type: Article

References (19)

1. Sabatine MS, Morrow DA, de Lemos JA, et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation. 2002;105:1760-3.
2. Omland T, Persson A, Ng L, et al. N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation. 2002;106:2913-8.
3. Jernberg T, Lindahl B, Siegbahn A, et al. N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease. J Am Coll Cardiol. 2003;42:1909-16.
4. Morrow DA, de Lemos JA, Sabatine MS, et al. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. J Am Coll Cardiol. 2003;41:1264-72.
5. James SK, Lindahl B, Siegbahn A, et al. N-terminal Pro-Brain Natriuretic Peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease. Circulation. 2003;108:275-81.
6. Jernberg T, James S, Lindahl B, Stridsberg M, Venge P, Wallentin L. NT-proBNP in unstable coronary artery disease - experience from the FAST, GUSTO IV and FRISC II trials. Eur J Heart Fail. 2004;6:319-25.
7. Heeschen C, Hamm CW, Motrovic V, et al. N-terminal pro-B-type Natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation. 2004;110:3206-12.
8. Goetze JP, Christoffersen M, Perko H, et al. Increased cardiac BNP expression associated with myocardial ischemia. FASEB J. 2003;17:1105-7.
9. Riezebos RK, Ronner E, de Boer BA, et al. Dynamics in NT-proBNP concentration in patients with NSTEACS. Am Heart J. 2005;150:1255-9.
10. Sabatine MS, Morrow DA, de Lemos JA, et al. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. J Am Coll Cardiol. 2004;44:1988-95.
11. Sadanandan S, Cannon CP, Chekuri K, et al. Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2004;44:564-8.
12. Yeo KJ, Wu AH, Apple FS, et al. Multicentre evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay. Clin Chim Acta. 2003;338:107-15.
13. Hallermayer K, Klenner D, Vogel R. Use of recombinant human cardiac troponin T for standardization of third generation troponin T methods. Scand J Clin Lab Invest. 1999;Suppl 230:128-31.
14. Wurzburg U, Hennrich N, Orth HD, et al. Quantitative determination of creatine kinase isoenzyme catalytic concentrations in serum using immunological methods. J Clin Chem Clin Biochem. 1977;15:131.
15. Kiemeneij F, Laarman GJ, Slagboom T, van der Wieken R. Outpatient coronary stent implantation. J Am Coll Cardiol. 1997;29:323-7.
16. Karha J, Murphy SA, Kirtane AJ, et al. Evaluation of the association of proximal coronary culprit artery lesion location with clinical outcomes in acute myocardial infarction. Am J Cardiol. 2003;92:913-8.
17. Talwar S, Squire IB, Davies JE. Plasma N-terminal probrain natriuretic peptide and the ECG in the assessment of left-ventricular systolic dysfunction in a high risk population. Eur Heart J. 1999;20:1736-44.
18. Ioannidis JPA, Karvourni E, Katritis DG. Mortality risk conferred by small elevations of creatinine kinase-MB isoenzyme after percutaneous intervention. J Am Coll Cardiol. 2003;42:1406-11.
19. De Winter RJ, Windhausen F, Cornel JH, et al. Early invasive versus selective invasive managements for acute coronary syndromes. N Engl J Med. 2005;353:1095-104.